Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting

Cisplatin is commonly recognized as a DNA-damaging drug; however, its versatile antitumor effects have been demonstrated to extend beyond this narrow functional attribute. The present study determined how cisplatin regulates alternative pathways and transcription factors to exert its additional anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Jinn-Rung, Shang, Hung-Sheng, Ho, Chun-Te, Lai, Kun-Goung, Liu, Tsan-Zon, Chen, Yin-Ju, Chiou, Jeng-Fong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104157/
https://www.ncbi.nlm.nih.gov/pubmed/27895723
http://dx.doi.org/10.3892/ol.2016.5181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104157/
https://www.ncbi.nlm.nih.gov/pubmed/27895723
http://dx.doi.org/10.3892/ol.2016.5181

Ejemplares similares